Link(The Guardian) Safety profile for once-weekly Ozempic (semaglutide) injection
(2024) 14:e091223
*Correspondence: Juan Pablo Del Ro, [email protected] This article was submitted to Neuroendocrine Science, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
- La semaglutida oral es eficaz, segura y bien tolerada en pacientes con DM2, incluso en aquellos con ERD, con los beneficios propios de esta familia de frmacos, lo que puede facilitar la introduccin ms precoz de un arGLP-1 en el manejo de la DM2
A., Guo, Y., Wang, H., Zhao, G., Liang, W., Yu, Y.,
H.PetersonR